Filters

HGV Polyprotein Antibody

HGV Polyprotein Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameHGV Polyprotein Primary Polyclonal Antibody
Also known asHGV Polyprotein PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenHGV Polyprotein
SpecificityThis is a highly specific antibody against HGV Polyprotein
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range2420-2439/2842
SourceKLH conjugated synthetic peptide derived from Hepatitis G Virus Polyprotein
Swiss ProtQ9DXH4
Tested Applications IF(IHC-P), IHC-P
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500)
Cross reactivityVirus
Cross reactive species detailsHepatitis G Virus
Background of the target antigen GB virus B and GB virus C) and is also designated as GB virus C (GBV C), HGV infection appears to be transmitted following receipt of blood from HGV RNA positive donors, HGV is a positive stranded RNA virus, however, on the basis of genome length and organisation, these patients have only moderate liver enzyme elevations and do not develop chronic liver disease, to be a member of the Flaviviridae and distinct from the hepatitis C virus (HCV), with a genome of 10 KB and appears, Hepatitis G virus is from a group of viruses called GB viruses (GB virus A
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names HGV, Hepatitis G Virus, Hepatitis GB virus C, Polyprotein [Hepatitis G virus isolate PE]
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetHGV Polyprotein
Short nameHGV Polyprotein Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameHGV Polyprotein (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter